Connect your AI

Gilead Sciences GILD Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers SquibbBMY

$1.1B-43.5%

IncyteINCY

$369.35M+38.8%

ImmunityBio, Inc.IBRX

-$75.36M+12.3%

PrecigenPGEN

-$43.83M-168%

AnaptysBio, Inc.ANAB

-$25.92M-142%

Sutro BiopharmaSTRO

-$42.26M+37.7%

Other financials

Income statement

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

Market cap$153.76B+13.9%

Enterprise value$168.3B+10.7%

P/E16.7×-5.9×

P/S5.2×+0.5×

Profitability

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Gilead Sciences's operating cash flow?: Gilead Sciences (GILD) reported operating cash flow of $2.54B in Q1 2026.
How has Gilead Sciences's operating cash flow changed year-over-year?: Gilead Sciences's operating cash flow increased by 44.8% year-over-year, from $1.76B to $2.54B.
What is the long-term trend for Gilead Sciences's operating cash flow?: Over 4 years (2021 to 2025), Gilead Sciences's operating cash flow has grown at a -3.1% compound annual growth rate (CAGR), from $11.38B to $10.02B.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.